Tema ETF Trust Tema Heart & Health ETF

HRTS

Market cap $52.2M

Overview Fund Activity

30.15 USD

-0.30

0.99%

At close Updated Sep 15, 4:00 PM EDT

1 day

-0.99%

5 days

-1.08%

1 month

3.04%

3 months

5.35%

6 months

-0.2%

Year to date

3.32%

1 year

-13.68%

5 years

13.22%

10 years

13.22%

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.16% more ownership

Funds ownership: 24.36% [Q1] → 24.52% (+0.16%) [Q2]

5% less funds holding

Funds holding: 21 [Q1] → 20 (-1) [Q2]

15% less capital invested

Capital invested by funds: $14.6M [Q1] → $12.5M (-$2.13M) [Q2]

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

See Fund Rankings

Financial journalist opinion

Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires

NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), the New York-based provider of innovative exchange traded funds (ETFs), has surpassed $1 billion in assets under management (AUM) in just two years since launch, achieved with less than $5m of initial seed AUM. Tema also announces the hiring of Devan O'Dowd as Head of Distribution and Ceri Llewelyn as Director of Marketing. Three highlights to note: Institutional Adoption: Tema estimates that over 90% of current AUM originates from Registered Inves.

Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires

New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs

For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to consider the investment opportunity in weight loss as a theme.

New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs

Disruptive Theme of the Week: 2024's Top Investment Themes & Trends

2024 was an amazing year for investment performance, with the broad market S&P 500 TR Index up over 28%. There were also some serious ETF milestones achieved this year.

Disruptive Theme of the Week: 2024's Top Investment Themes & Trends

Disruptive Theme of the Week – Breakthroughs in Medicine

Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.

Disruptive Theme of the Week – Breakthroughs in Medicine

Disruptive Theme of the Week: Happy Post-Election Themes

With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to consider for investment.

Disruptive Theme of the Week: Happy Post-Election Themes

Zacks Investment Research

Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications.

Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

Zacks Investment Research

Tap the Weight-Loss Drug Market With These ETFs

Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.

Tap the Weight-Loss Drug Market With These ETFs

Disruptive Theme of the Week: Playing Defense

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

Disruptive Theme of the Week: Playing Defense

How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)

The weight loss revolution sparked by Novo Nordisk last year is attracting many investors towards the high risk biotech sector. An ETF like HRTS gives a lower risk exposure to the sector.

How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)

HRTS: Generating Alpha In Obesity Treatment

The Tema Obesity & Cardiometabolic ETF is a new actively managed fund focusing on the obesity treatment market. The investment strategy includes a mix of cash flow-positive companies, high-growth companies, and start-ups with promising technology. An interview with the PM increased my understanding and confidence in the portfolio construction and strategy.

HRTS: Generating Alpha In Obesity Treatment

See News Rankings

Charts implemented using Lightweight Charts™